首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Serological detection of cutaneous T-cell Iymphoma-associated antigens
【24h】

Serological detection of cutaneous T-cell Iymphoma-associated antigens

机译:皮肤T细胞淋巴瘤相关抗原的血清学检测

获取原文
获取原文并翻译 | 示例
       

摘要

Cutaneous T-cell lymphomas (CTCL) are a group of skin neoplasms that originate from T lymphocytes and are difficult to treat in advanced stages. The present study is aimed at the identification of tumor-specific antigens from a human testis cDNA library using human sera known as the SEREX (serological identification of recombinantly expressed genes) approach. A cDNA library from normal testicle tissue was prepared and approximately 2 milIion recombinants were screened with sera from Sezary Syndrome and Mycosis fungoides patients. A total of 28 positive clones belonging to 15 different genes/ORFs were identified, including five hitherto unknown sequences. Whereas control sera did not react with most clones, 11--71/100 sera from CTCL patients were reactive against the identified clones. Expression analysis on 28 normal control and 17 CTCL tissues by reverse transcription--PCR (RT-PCR) and Northern blotting revealed seven ubiquitously distributed antigens. six dif- ferentially expressed antigens (several normal tissues were posi- tive), and two tumor-specific antigens that were expressed only in testis and tumor tissues: (Ⅰ) A SCP-1-like sequence, which has already been detected in various tumors. has been found in one CTCL tumor and four sera of CTCL patients reacted with various SCP-1-like clones and (Ⅱ) a new sequence named cTAGE-1 (CTCL- associated antigen 1) was detected in 35/100 of CTCL tumor tissues and sera of 6/18 patients reacted with this clone. The present study unravels CTCL-associated antigens independent of the T-cell re- ceptor. The SCP-1-like gene and cTAGE-1 were shown to be immu- nogenic and immunologically tumor-specific and may therefore be candidates for immunotherapy targeting CTCL
机译:皮肤T细胞淋巴瘤(CTCL)是一组皮肤肿瘤,起源于T淋巴细胞,难以晚期治疗。本研究旨在使用称为SEREX(重组表达基因的血清学鉴定)方法的人血清从人睾丸cDNA文库中鉴定肿瘤特异性抗原。制备了来自正常睾丸组织的cDNA文库,并用来自Sezary综合症和真菌病患者的血清筛选了大约200万个重组体。总共鉴定了属于15个不同基因/ ORF的28个阳性克隆,包括五个迄今未知的序列。对照血清对大多数克隆无反应,而CTCL患者的11--71 / 100血清对鉴定出的克隆有反应性。通过逆转录PCR(RT-PCR)和Northern杂交在28例正常对照和17例CTCL组织中进行表达分析,发现了7种普遍分布的抗原。六个差异表达的抗原(几个正常组织是阳性的),和两个仅在睾丸和肿瘤组织中表达的肿瘤特异性抗原:(Ⅰ)一个类似于SCP-1的序列,已经在各种方法中被检测到。肿瘤。在一个CTCL肿瘤中发现了四例CTCL患者的血清,并与各种SCP-1样克隆发生了反应;(Ⅱ)在35/100个CTCL肿瘤组织中发现了一个名为cTAGE-1(CTCL相关抗原1)的新序列。 6/18患者的血清对此克隆有反应。本研究揭示了与T细胞受体无关的CTCL相关抗原。已显示SCP-1样基因和cTAGE-1具有免疫原性和免疫学肿瘤特异性,因此可能是针对CTCL的免疫疗法的候选药物

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号